1832 Asset Management L.P. continued to hold its position in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 89,800 shares of the company’s stock at the end of the second quarter. 1832 Asset Management L.P. owned approximately 0.23% of Intuitive Surgical worth $58,506,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Global X Management Co. LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at about $118,000. Bartlett & Co. LLC increased its position in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares in the last quarter. Glenmede Trust Co. NA increased its position in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares in the last quarter. Thompson Davis & CO. Inc. increased its position in shares of Intuitive Surgical by 11.6% in the second quarter. Thompson Davis & CO. Inc. now owns 327 shares of the company’s stock worth $216,000 after buying an additional 34 shares in the last quarter. Finally, Princeton Alpha Management LP bought a new position in shares of Intuitive Surgical during the second quarter worth $239,000. 92.03% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) traded down 2.17% during mid-day trading on Friday, hitting $621.76. 706,391 shares of the stock were exchanged. Intuitive Surgical Inc. has a 12-month low of $497.22 and a 12-month high of $727.25. The stock’s 50 day moving average price is $692.19 and its 200-day moving average price is $671.07. The stock has a market capitalization of $24.09 billion, a P/E ratio of 33.54 and a beta of 0.55.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 18th. The company reported $6.19 earnings per share for the quarter, beating analysts’ consensus estimates of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to the consensus estimate of $650.49 million. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The company’s revenue for the quarter was up 15.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.24 EPS. On average, equities research analysts expect that Intuitive Surgical Inc. will post $22.19 EPS for the current fiscal year.

ISRG has been the subject of a number of research analyst reports. Barclays PLC reaffirmed an “overweight” rating and issued a $760.00 target price (up from $750.00) on shares of Intuitive Surgical in a research note on Friday, October 21st. Evercore ISI reaffirmed a “buy” rating and issued a $775.00 target price (up from $750.00) on shares of Intuitive Surgical in a research note on Wednesday, July 20th. Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $750.00 to $760.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 19th. Zacks Investment Research downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, September 20th. Finally, Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a research note on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Intuitive Surgical presently has an average rating of “Buy” and an average target price of $729.50.

In other Intuitive Surgical news, CEO Gary S. Guthart sold 13,515 shares of the stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $680.68, for a total transaction of $9,199,390.20. Following the completion of the sale, the chief executive officer now owns 82,880 shares of the company’s stock, valued at approximately $56,414,758.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total transaction of $2,064,990.00. Following the sale, the senior vice president now directly owns 2,331 shares of the company’s stock, valued at approximately $1,604,497.23. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.